NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study

Clinical trial NCT07121374 · RECRUITING

Trial details

NCT number: NCT07121374
Sponsor: University Hospital, Antwerp
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pleural Epithelioid Mesothelioma Mesothelioma; Pleura Neoadjuvant Chemoimmunotherapy

Start date: 2025-07-22
Primary completion: 2028-06-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.